Stem Cell Therapy Market is expected to reach US$ 5,129.66 million in 2027

Published Date: 01 Apr 2020

Report : Stem Cell Therapy Market to 2027 - Global Analysis and Forecast by Type (Adult Stem Cell Therapy, Embryonic Stem Cell Therapy, Induced Pluripotent Stem Cell Therapy, Other Stem Cell Therapy); Treatment (Allogeneic, Autologous ); Application (Musculoskeletal, Dermatology, Cardiology, Drug Discovery and Development, Other Applications); End User (Hospitals and Specialty Clinics, Academic and Research Institutes), and Geography

Adult Stem CellSegment byTypeIs Projectedto Grow ata Fast Pace Overthe Forecast Period

 

According to The Insight Partners market research study of ‘Stem Cell therapyMarketto 2027 – Global Analysis and Forecasts by Type, Treatment, Application, and End User.’ The global stem cell therapy market is expected to reach US$ 5,129.66 Mn in 2027 from US$ 1,534.55 Mn in 2019. The market is estimated to grow with a CAGR of 16.7% from 2020-2027. The report provides trends prevailing in the global stem cell therapymarketand the factors driving market along with those that act as hindrances.

 

The global stem cell therapy market, based on the type, is segmented into adult stem cell, induced pluripotent stem cells, embryonic stem cell, and other stem cells. Adult stem cell therapy is further segmented into hematopoietic stem cells, mesenchymal stem cells, neuronal stem cells, and umbilical cord stem cells. The adult stem cellsegment held the largest share of the market in 2019. The same segment is estimated to register the highest CAGR in the market during the forecast perioddue to its effectiveness for the treatment of chronic conditions coupled with higher compatibility with immunity system. The end usersegment is segmented into academic and research institutes and hospitals & specialty clinics.

 

The stem cell therapy marketfor is expected to grow, owing to factors such Increasing awareness related to the stem cells therapy in effective disease management, growing demand for regenerative medicines, and growing cancer prevalence across the globe are likely to have a positive impact on the growth of the market in coming years.

 

Leading companies operating in the stem cell therapy marketare Medipost, pharmicell Co., Ltd., HolostemTerapieAvanzate S.R.L., Mesoblast Ltd., U.S. Stem Cell, Inc., Biotime, Inc., RichSource, Caladrius, TiGenix NV (Takeda Pharmaceuticals), and GeneaBiocellsamong others.

 

The report segments global stem cell therapy market as follows:

 

Global Stem Cell TherapyMarket – ByType

  • Adult Stem Cell Therapy
  • Embryonic Stem Cell Therapy
  • Induced Pluripotent Stem Cell Therapy
  • Other Stem Cell Therapy


Global Stem Cell Therapy Market – By Treatment

  • Allogeneic
  • Autologous


Global Stem Cell TherapyMarket – By Application

  • Musculoskeletal
  • Dermatology
  • Cardiology
  • Drug Discovery & Development
  • Other Applications


Global Stem Cell TherapyMarket – By End User

  • Hospitals & Specialty Clinics
  • Academic & Research Institutes Diagnostic Laboratories


Global Stem Cell therapyMarket– By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • U.A.E
    • South Africa
  • South & Central America (SCAM)
    • Brazil
    • Argentina

 

Contact Us

Contact Person: Sameer Joshi 

Phone: +1-646-491-9876

Email Id: sales@theinsightpartners.com

 

Download PDF Brochure